ISMP (US) Contact Us Feedback

ISMP Canada News

February 28, 2017: Your Feedback is Requested: Injectable Compounded Product Label Design for Safety

Label content and design have been identified as contributing factors to numerous medication incidents. It is crucial to consider the intended use of the product and the needs of the end user when designing product labels. ISMP Canada has developed checklists for the safe labelling of injectable compounded products. ISMP Canada is seeking consultation from compounded product providers (including manufacturers and commercial compounders, and community pharmacy and hospital compounders), as well as any other interested stakeholders.  Read more ...